Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy

We aimed to evaluate the effectiveness and safety of bismuth-containing quadruple therapy plus postural change after dosing for Helicobacter pylori eradication in gastrectomized patients. We compared 76 gastric stump patients with H. pylori infection (GS group) with 50 non-gastrectomized H. pylori-positive patients who met the treatment indication (controls). The GS group was divided into GS group 1 and GS group 2. All groups were administered bismuth potassium citrate (220 mg), esomeprazole (20 mg), amoxicillin (1.0 g), and furazolidone (100 mg) twice daily for 14 days. GS group 1 maintained a left lateral horizontal position for 30 min after dosing. H. pylori was detected using rapid urease testing and histologic examination of gastric mucosa before and 3 months after therapy. Mucosal histologic manifestations were evaluated using visual analog scales of the updated Sydney System. GS group 1 had a higher prevalence of eradication than the GS group 2 (intention-to-treat [ITT]: P=0.025; per-protocol [PP]: P=0.030), and the control group had a similar prevalence. GS group 2 had a lower prevalence of eradication than controls (ITT: P=0.006; PP: P=0.626). Scores for chronic inflammation and activity declined significantly (P<0.001) 3 months after treatment, whereas those for atrophy and intestinal metaplasia showed no significant change. Prevalence of adverse reactions was similar among groups during therapy (P=0.939). A bismuth-containing quadruple therapy regimen plus postural change after dosing appears to be a relatively safe, effective, economical, and practical method for H. pylori eradication in gastrectomized patients.

Saved in:
Bibliographic Details
Main Authors: Zhang,F., Bao,Z.J., Shi,D.M., Xiang,P., Xiao,L., Huang,Y.Q., Zhang,G.S., Yin,S.M.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000200702
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2016000200702
record_format ojs
spelling oai:scielo:S0100-879X20160002007022016-02-01Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomyZhang,F.Bao,Z.J.Shi,D.M.Xiang,P.Xiao,L.Huang,Y.Q.Zhang,G.S.Yin,S.M. Helicobacter pylori Gastrectomy Gastric stump Eradication Efficacy We aimed to evaluate the effectiveness and safety of bismuth-containing quadruple therapy plus postural change after dosing for Helicobacter pylori eradication in gastrectomized patients. We compared 76 gastric stump patients with H. pylori infection (GS group) with 50 non-gastrectomized H. pylori-positive patients who met the treatment indication (controls). The GS group was divided into GS group 1 and GS group 2. All groups were administered bismuth potassium citrate (220 mg), esomeprazole (20 mg), amoxicillin (1.0 g), and furazolidone (100 mg) twice daily for 14 days. GS group 1 maintained a left lateral horizontal position for 30 min after dosing. H. pylori was detected using rapid urease testing and histologic examination of gastric mucosa before and 3 months after therapy. Mucosal histologic manifestations were evaluated using visual analog scales of the updated Sydney System. GS group 1 had a higher prevalence of eradication than the GS group 2 (intention-to-treat [ITT]: P=0.025; per-protocol [PP]: P=0.030), and the control group had a similar prevalence. GS group 2 had a lower prevalence of eradication than controls (ITT: P=0.006; PP: P=0.626). Scores for chronic inflammation and activity declined significantly (P<0.001) 3 months after treatment, whereas those for atrophy and intestinal metaplasia showed no significant change. Prevalence of adverse reactions was similar among groups during therapy (P=0.939). A bismuth-containing quadruple therapy regimen plus postural change after dosing appears to be a relatively safe, effective, economical, and practical method for H. pylori eradication in gastrectomized patients.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.49 n.2 20162016-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000200702en10.1590/1414-431X20155080
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Zhang,F.
Bao,Z.J.
Shi,D.M.
Xiang,P.
Xiao,L.
Huang,Y.Q.
Zhang,G.S.
Yin,S.M.
spellingShingle Zhang,F.
Bao,Z.J.
Shi,D.M.
Xiang,P.
Xiao,L.
Huang,Y.Q.
Zhang,G.S.
Yin,S.M.
Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
author_facet Zhang,F.
Bao,Z.J.
Shi,D.M.
Xiang,P.
Xiao,L.
Huang,Y.Q.
Zhang,G.S.
Yin,S.M.
author_sort Zhang,F.
title Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
title_short Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
title_full Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
title_fullStr Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
title_full_unstemmed Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
title_sort efficacy of a quadruple therapy regimen for helicobacter pylori eradication after partial gastrectomy
description We aimed to evaluate the effectiveness and safety of bismuth-containing quadruple therapy plus postural change after dosing for Helicobacter pylori eradication in gastrectomized patients. We compared 76 gastric stump patients with H. pylori infection (GS group) with 50 non-gastrectomized H. pylori-positive patients who met the treatment indication (controls). The GS group was divided into GS group 1 and GS group 2. All groups were administered bismuth potassium citrate (220 mg), esomeprazole (20 mg), amoxicillin (1.0 g), and furazolidone (100 mg) twice daily for 14 days. GS group 1 maintained a left lateral horizontal position for 30 min after dosing. H. pylori was detected using rapid urease testing and histologic examination of gastric mucosa before and 3 months after therapy. Mucosal histologic manifestations were evaluated using visual analog scales of the updated Sydney System. GS group 1 had a higher prevalence of eradication than the GS group 2 (intention-to-treat [ITT]: P=0.025; per-protocol [PP]: P=0.030), and the control group had a similar prevalence. GS group 2 had a lower prevalence of eradication than controls (ITT: P=0.006; PP: P=0.626). Scores for chronic inflammation and activity declined significantly (P<0.001) 3 months after treatment, whereas those for atrophy and intestinal metaplasia showed no significant change. Prevalence of adverse reactions was similar among groups during therapy (P=0.939). A bismuth-containing quadruple therapy regimen plus postural change after dosing appears to be a relatively safe, effective, economical, and practical method for H. pylori eradication in gastrectomized patients.
publisher Associação Brasileira de Divulgação Científica
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000200702
work_keys_str_mv AT zhangf efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT baozj efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT shidm efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT xiangp efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT xiaol efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT huangyq efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT zhanggs efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
AT yinsm efficacyofaquadrupletherapyregimenforhelicobacterpylorieradicationafterpartialgastrectomy
_version_ 1756391512245010432